Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

More children than ever taking anti-obesity drugs

  • Comment

More children are taking anti-obesity drugs than ever before, but give up before the treatment can take effect, according to data.

A study found that 15 times the amount of under-18s are using the medicines compared to 1999, estimating that about 1,300 youngsters are prescribed them every year.

Yet anti-obesity drugs are only licensed for adults, meaning family doctors are offering them to children off-label.

Researchers examined the use of orlistat (Xenical), sibutramine (Reductil) and rimonabant (Acomplia) in under-18s, focusing on prescribing data between January 1 1999 and December 31 2006 from the UK General Practice Research Database.

They found that 1,334 prescriptions were given out to 452 youngsters in that period.

Russell Viner, one of the authors of the study published in the British Journal of Clinical Pharmacology, said: ‘It’s possible that the drugs are being given inappropriately, or that they have excessive side effects that make young people discontinue their use.

‘On the other hand, they could be expecting the drugs to deliver a miracle ‘quick fix’ and stop using them when sudden, rapid weight loss does not occur.’

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs